According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 93.8032. At the end of 2023 the company had a P/S ratio of 95.3.
Year | P/S ratio | Change |
---|---|---|
2023 | 95.3 | -84.47% |
2022 | 614 | |
2021 | N/A |